BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND RET, RET51, 5979, P07949, ENSG00000165731, MTC1, MEN2A, RET-ELE1, HSCR1, MEN2B, CDHF12 AND Clinical Outcome
45 results:

  • 1. Approach to risk stratification for papillary thyroid carcinoma based on molecular profiling: institutional analysis.
    Staubitz JI; Müller C; Heymans A; Merten C; Roos B; Poplawski A; Ludt A; Strobl S; Springer E; Schad A; Roth W; Musholt TJ; Hartmann N
    BJS Open; 2023 May; 7(3):. PubMed ID: 37146205
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Modifier Role of Common
    Skalniak A; Trofimiuk-Müldner M; Przybylik-Mazurek E; Hubalewska-Dydejczyk A
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769224
    [No Abstract]    [Full Text] [Related]  

  • 3. Cystic ovarian teratoma as a novel tumor and growth hormone deficiency as a new condition presenting in Multiple Endocrine Neoplasia type 2B: Case reports and review of the literature.
    Pomahacova R; Paterova P; Nykodymova E; Vaclavikova E; Sykorova P; Personova K; Katra R; Subrt I; Sykora J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Mar; 166(1):105-111. PubMed ID: 34446941
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Correlation of molecular data with histopathological and clinical features in a series of 66 patients with medullary thyroid carcinoma.
    Moura MM; Cabrera RA; Esteves S; Cavaco BM; Soares P; Leite V
    J Endocrinol Invest; 2021 Sep; 44(9):1837-1846. PubMed ID: 33575974
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. ret Copy Number Alteration in Medullary thyroid cancer Is a Rare Event Correlated with ret Somatic Mutations and High Allelic Frequency.
    Ramone T; Mulè C; Ciampi R; Bottici V; Cappagli V; Prete A; Matrone A; Piaggi P; Torregrossa L; Basolo F; Elisei R; Romei C
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33383911
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Molecular characterisation and clinical correlation of papillary thyroid microcarcinoma.
    Samà MT; Grosso E; Mele C; Laurora S; Monzeglio O; Marzullo P; Boldorini R; Aluffi Valletti P; Aimaretti G; Scatolini M; Pagano L
    Endocrine; 2021 Jan; 71(1):149-157. PubMed ID: 32621051
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Modulatory Role of Single Nucleotide Polymorphisms of Distinct Genetic Pathways on clinical Behavior of Medullary thyroid Carcinoma.
    Mishra V; Kowtal P; Rane P; Sarin R
    Asian Pac J Cancer Prev; 2020 May; 21(5):1289-1293. PubMed ID: 32458635
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. GADD45B Transcript Is a Prognostic Marker in Papillary thyroid Carcinoma Patients Treated With Total thyroidectomy and Radioiodine Therapy.
    Barros-Filho MC; de Mello JBH; Marchi FA; Pinto CAL; da Silva IC; Damasceno PKF; Soares MBP; Kowalski LP; Rogatto SR
    Front Endocrinol (Lausanne); 2020; 11():269. PubMed ID: 32425887
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Macrofollicular Variant of Follicular thyroid Carcinoma: A Rare Underappreciated Pitfall in the Diagnosis of thyroid Carcinoma.
    Bongiovanni M; Sykiotis GP; La Rosa S; Bisig B; Trimech M; Missiaglia E; Gremaud M; Salvatori Chappuis V; De Vito C; Sciarra A; Foulkes WD; Pusztaszeri M
    Thyroid; 2020 Jan; 30(1):72-80. PubMed ID: 31701808
    [No Abstract]    [Full Text] [Related]  

  • 10. Genetic landscape of papillary thyroid carcinoma in the Chinese population.
    Liang J; Cai W; Feng D; Teng H; Mao F; Jiang Y; Hu S; Li X; Zhang Y; Liu B; Sun ZS
    J Pathol; 2018 Feb; 244(2):215-226. PubMed ID: 29144541
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Current Advances in thyroid cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?
    Rusinek D; Chmielik E; Krajewska J; Jarzab M; Oczko-Wojciechowska M; Czarniecka A; Jarzab B
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28829399
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. ATF4 Targets ret for Degradation and Is a Candidate Tumor Suppressor Gene in Medullary thyroid cancer.
    Bagheri-Yarmand R; Williams MD; Grubbs EG; Gagel RF
    J Clin Endocrinol Metab; 2017 Mar; 102(3):933-941. PubMed ID: 27935748
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Application of molecular biology of differentiated thyroid cancer for clinical prognostication.
    Marotta V; Sciammarella C; Colao A; Faggiano A
    Endocr Relat Cancer; 2016 Nov; 23(11):R499-R515. PubMed ID: 27578827
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications.
    Joung JY; Kim TH; Jeong DJ; Park SM; Cho YY; Jang HW; Jung YY; Oh YL; Yim HS; Kim YL; Chung JH; Ki CS; Kim SW
    Histopathology; 2016 Jul; 69(1):45-53. PubMed ID: 26568156
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Surgical Treatment of Medullary thyroid cancer.
    Machens A; Dralle H
    Recent Results Cancer Res; 2015; 204():187-205. PubMed ID: 26494390
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumours.
    Sponziello M; Durante C; Boichard A; Dima M; Puppin C; Verrienti A; Tamburrano G; Di Rocco G; Redler A; Lacroix L; Bidart JM; Schlumberger M; Damante G; Russo D; Filetti S
    Mol Cell Endocrinol; 2014 Jul; 392(1-2):8-13. PubMed ID: 24813658
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Vandetanib: in medullary thyroid cancer.
    Frampton JE
    Drugs; 2012 Jul; 72(10):1423-36. PubMed ID: 22715896
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Correlation of ret somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas.
    Moura MM; Cavaco BM; Pinto AE; Domingues R; Santos JR; Cid MO; Bugalho MJ; Leite V
    Br J Cancer; 2009 Jun; 100(11):1777-83. PubMed ID: 19401695
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The prevalence of ret/PTC mutations in papillary thyroid cancers in Turkish population and its relation between tumor histopathology and prognostic factors.
    Erdoğan M; Berdeli A; Karadeniz M; Ertan Y; Cetinkalp S; Saygili F; Tuncyurek M; Yilmaz C; Tuzun M; Kabalak T; Uluer H; Ozgen AG
    Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):225-30. PubMed ID: 18393128
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Molecular biology of thyroid cancer initiation.
    Riesco-Eizaguirre G; Santisteban P
    Clin Transl Oncol; 2007 Nov; 9(11):686-93. PubMed ID: 18055323
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.